According to Zeria Pharmaceutical's latest financial reports the company has $0.13 Billion USD in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-03-31 | $0.13 B | 10.25% |
2023-03-31 | $0.12 B | 26.94% |
2022-03-31 | $95.92 M | 8% |
2021-03-31 | $88.81 M | 6.55% |
2020-03-31 | $83.35 M | 15% |
2019-03-31 | $72.48 M | -24.26% |
2018-03-31 | $95.69 M | 14.4% |
2017-03-31 | $83.65 M | -23.84% |
2016-03-31 | $0.10 B | -26.81% |
2015-03-31 | $0.15 B | -30.45% |
2014-03-31 | $0.21 B | 176.16% |
2013-03-31 | $78.13 M | 13.34% |
2012-03-31 | $68.94 M | 15.82% |
2011-03-31 | $59.52 M | 55.75% |
2010-03-31 | $38.22 M | 34.49% |
2009-03-31 | $28.42 M | 14.24% |
2008-03-31 | $24.87 M | 36.11% |
2007-03-31 | $18.27 M | 0.24% |
2006-03-31 | $18.23 M |